Search - tctmd.com

Displaying 181 - 200 of 267

Sort: Relevancy | Date

News Daily News

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

Michael O'Riordan

September 16, 2020

News Daily News

PCI Volumes Rise in US and Japan, but for Different Reasons

Michael O'Riordan

September 14, 2020

News Daily News

Which TAVR Device Is Best? Review Tackles Optimal Selection

Michael O'Riordan

September 09, 2020

News Daily News

Better Outcomes, Including Mortality, With IVUS-Guided PCI: Medicare Analysis

Michael O'Riordan

August 18, 2020

News Daily News

Missing EXCEL MI Data Published, Prompting New Questions and Promised Answers

Michael O'Riordan

August 07, 2020

News Daily News

Polymer-Free DES Hold No Long-term Advantage: ISAR-TEST-5

Michael O'Riordan

July 07, 2020

News Conference News EuroPCR 2020

Tirofiban Provides Better Platelet Inhibition Than Cangrelor in STEMI Patients

Michael O'Riordan

June 30, 2020

News Conference News EuroPCR 2020

No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms

Michael O'Riordan

June 26, 2020

News Conference News TVT 2020

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

Michael O'Riordan

June 23, 2020

News Conference News TVT 2020

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

Michael O'Riordan

June 22, 2020

News Daily News

PCI for Left Main CAD: Meta-analysis Finds No Increased Risk of Mortality

Michael O'Riordan

June 12, 2020

News Daily News

Myocardial Injury Seen in Over One-Third of Hospitalized COVID-19 Patients

Michael O'Riordan

June 10, 2020

News Features

The Next Blaze: Pandemic Burnout Among Health Professionals

Michael O'Riordan

June 05, 2020

News Daily News

New EXCEL Analysis Reignites Debate Over PCI for Left Main CAD

Michael O'Riordan

June 01, 2020

Lancet COVID-19 Hydroxychloroquine Study Faces ‘Data Integrity’ Questions

News Daily News

TAVR Bests Surgical Redo for Failed Bioprostheses: Early Data

Michael O'Riordan

June 01, 2020

News Daily News

Good Results With Next-Gen, Self-Expanding TAVR in Bicuspid Valves

Michael O'Riordan

May 27, 2020

News Daily News

Patterns of COVID-19 in Health Professionals Offers Clues for Disease Control

Michael O'Riordan

May 22, 2020

News Conference News HRS 2020

Permanent Conduction-System Pacing After TAVR? Don’t ‘Diss the His’

Michael O'Riordan

May 21, 2020

News Features

Hospitals Plan Cautious Restart to Elective Procedures as COVID-19 Wanes

Michael O'Riordan

May 12, 2020

News Daily News

Clopidogrel Holds Advantage in Older NTSE ACS Patients: POPular AGE Published

Michael O'Riordan

April 27, 2020

Advertisement

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

PCI Volumes Rise in US and Japan, but for Different Reasons

Which TAVR Device Is Best? Review Tackles Optimal Selection

Better Outcomes, Including Mortality, With IVUS-Guided PCI: Medicare Analysis

Missing EXCEL MI Data Published, Prompting New Questions and Promised Answers

Polymer-Free DES Hold No Long-term Advantage: ISAR-TEST-5

Tirofiban Provides Better Platelet Inhibition Than Cangrelor in STEMI Patients

No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

PCI for Left Main CAD: Meta-analysis Finds No Increased Risk of Mortality

Myocardial Injury Seen in Over One-Third of Hospitalized COVID-19 Patients

The Next Blaze: Pandemic Burnout Among Health Professionals

New EXCEL Analysis Reignites Debate Over PCI for Left Main CAD

TAVR Bests Surgical Redo for Failed Bioprostheses: Early Data

Good Results With Next-Gen, Self-Expanding TAVR in Bicuspid Valves

Patterns of COVID-19 in Health Professionals Offers Clues for Disease Control

Permanent Conduction-System Pacing After TAVR? Don’t ‘Diss the His’

Hospitals Plan Cautious Restart to Elective Procedures as COVID-19 Wanes

Clopidogrel Holds Advantage in Older NTSE ACS Patients: POPular AGE Published

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content